16 results
PRE 14A
IMNM
Immunome, Inc.
7 Apr 23
Preliminary proxy
6:29am
requirements of the Company and the long-term interests of the Company’s stockholders. In conducting this assessment, the Board considers diversity, age … policy on Board diversity, the Nominating and Corporate Governance Committee considers the value of diversity on the Board in evaluating director
8-K
EX-99.1
IMNM
Immunome, Inc.
15 Nov 22
Other Events
4:17pm
CD19 Current Therapies are Based on a Limited Knowledge of the Diversity and Complexity within the Context of Human Tumors Novel targets have
8-K
EX-99.1
pqmzs9ut 6cnxas
26 Apr 21
Regulation FD Disclosure
6:07am
DEF 14A
zosgpw nuurzibnt79tt
16 Apr 21
Definitive proxy
3:35pm
8-K
EX-99.1
uqx9ixk766wkynb
29 Mar 21
Regulation FD Disclosure
6:02am
10-K
esaf4vno523
25 Mar 21
Annual report
5:01pm
8-K
EX-99.1
a7sbe12 et72bnp
16 Mar 21
Regulation FD Disclosure
6:00am
8-K
EX-99.1
depveha3 8pysh
26 Oct 20
Regulation FD Disclosure
8:30am
424B4
6zyx 16zdza
5 Oct 20
Prospectus supplement with pricing info
5:10pm
S-1/A
vvw3qkggop fd
24 Sep 20
IPO registration (amended)
7:18am
S-1
j8vfz39wp3zdyi51 k1
9 Sep 20
IPO registration
4:19pm
DRS
yjfon cmzn2vdyd6wsja
12 Aug 20
Draft registration statement
12:00am
- Prev
- 1
- Next